New Diabetes Diagnosis? Cancer Risk May Rise Too

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth Research Institute
Topics:
Care

A new study reveals that people newly diagnosed with Type 2 diabetes face a significantly higher risk of developing aggressive cancers—including those of the liver, pancreas, and colon.

While obesity has long been linked to these cancers, the research suggests Type 2 diabetes itself may be an independent driver of cancer risk. The findings, presented at the 2025 European Congress on Obesity, analyzed data from over 23,000 people in the U.K. Biobank with new-onset Type 2 diabetes and compared them to more than 71,000 non-diabetic individuals of similar age, sex, and weight.

Over five years, cancer risk was clearly higher in the diabetes group:

  • Liver cancer risk was nearly 4 times higher in men and 5 times higher in women.
  • Pancreatic cancer risk rose 74% in men, nearly doubled in women.
  • Colorectal cancer risk increased by more than 25% in both groups.

Lead author Owen Tipping from the University of Manchester said the link may stem from factors like inflammation, insulin resistance, or gut microbiome changes—beyond just excess weight.

Experts say more research is needed but agree the findings highlight the importance of early detection, healthy lifestyle changes, and ongoing monitoring. “This isn’t a reason to panic,” said oncologist Dr. Jack Jacoub. “It’s a reason to take action—through diet, exercise, and good blood sugar control.”

The takeaway? Type 2 diabetes may do more than disrupt blood sugar—it could quietly raise your cancer risk too.

Source: https://www.ajmc.com/view/new-onset-type-2-diabetes-linked-to-higher-cancer-risk?utm_source=chatgpt.com

Recent News

News
Dr. Pratley Featured on Healio Endocrinology

Dr. Richard Pratley, Samuel E. Crockett Chair in Diabetes Research and Medical Director of AdventHealth Diabetes Institute, recently shared insights with Healio Endocrinology about the importance of...

Read Article
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...

Read Article
News
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes

Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...

Read Article
News
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training

“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...

Read Article
View More Articles